NAGAILEBEN to buy back up to 600,000 shares, stock surges for second straight session

NAGAILEBEN Co., Ltd. <7447> extended sharp gains for a second straight session after announcing after the close on Oct. 1 a share buyback program, providing a positive catalyst. The company set a limit to repurchase up to 600,000 shares (2.04% of issued shares excluding treasury stock) for up to 1 billion yen, with the acquisition period running from Oct. 2 to Dec. 31. The buyback aims to enhance shareholder value through a flexible capital policy.

NAGAILEBEN also released its consolidated earnings forecast for the fiscal year ending August 2027, projecting net sales of 17.5 billion yen (up 1.7% year-on-year), operating profit of 3.62 billion yen (down 0.7%), and net profit of 2.66 billion yen (up 0.4%). In its core market for medical and nursing care uniforms, the company aims to win model renewals and new accounts through new launches in its strong-performing Miffy line. In peripheral markets, it plans to revive sluggish patient wear sales by capturing replacement demand and boosting high-value-added products, while expanding surgical wear revenue through deeper market penetration of Compel Pack. However, high raw material prices and rising labor costs are expected to weigh on profits.

For the fiscal year ended August 2026, NAGAILEBEN reported net sales of 17.205 billion yen (up 1.3% year-on-year), operating profit of 3.625 billion yen (up 1.2%), and net profit of 2.65 billion yen (up 3.0%).

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.